Annovis Bio, Inc.

ANVS · Healthcare · Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States

Annovis Bio, Inc. (ANVS), in the Healthcare sector, has 7 disclosed filings on Paydirt over the trailing twelve months from 2 corporate insiders: 7 purchases and 0 sales, 2 filed past the deadline. Filers took a median of 1 day from execution to disclosure, and the most recent trade was executed May 20 and filed May 22. The most active filer was Michael B Hoffman with 6 filings.

Add to watchlist

Filings, ttm

7 buys · 0 sells · 2 late

Traders, ttm

2 insiders

Volume, ttmiDollar value disclosed in the window

$4.2M

estimated for Congress, as filed for insiders

Median delay

execution to disclosure

Last traded

May 20

Filed May 21

ADViAverage daily dollar volume

–

not on file

Share price · 12M

$1.84 (-20.7%)

Adjusted for splits and dividends.

Volume by month

Buys $4.2M Sells $0

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed

Michael B Hoffman Director 6 filings MM

Maria-Luisa Maccecchini President & CEO 1 filing

Recent filings

Michael B HoffmanPURCHASE Director $104K
54,933 sh × $1.90
Exec May 20
Filed May 21 · 8:11 PM ET Michael B HoffmanPURCHASE Director $1.5M
713,800 sh × $2.10
Exec Apr 2
Filed Apr 3 · 5:06 PM ET Michael B HoffmanPURCHASE Director $130K
30,000 sh × $4.34
Exec Dec 8 2025
Filed Dec 8 2025 · 8:05 PM ET Michael B HoffmanPURCHASE Director $117K
28,096 sh × $4.15
Exec Nov 24 2025
Filed Nov 25 2025 · 6:59 PM ET Michael B HoffmanPURCHASE Director $117K
28,096 sh × $4.15
Exec Nov 24 2025
Filed Nov 25 2025 · 12:26 PM ET Maria-Luisa MaccecchiniPURCHASE President & CEO $200K
97,561 sh × $2.05
Exec Oct 28 2025
Filed Nov 12 2025 · 9:19 AM ET † Michael B HoffmanPURCHASE Director $2.0M
975,610 sh × $2.05
Exec Oct 28 2025
Filed Nov 12 2025 · 9:18 AM ET †